Works by Tawon, Yardpiroon

Results: 8
    1

    No significant drug−drug interaction between oral TAF‐based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT‐3 study.

    Published in:
    Journal of the International AIDS Society, 2025, v. 28, n. 5, p. 1, doi. 10.1002/jia2.26502
    By:
    • Hiransuthikul, Akarin;
    • Thammajaruk, Narukjaporn;
    • Kerr, Stephen;
    • Janamnuaysook, Rena;
    • Nonenoy, Siriporn;
    • Hongchookiat, Piranun;
    • Trichavaroj, Rapee;
    • Tawon, Yardpiroon;
    • Boonruang, Jakkrapatara;
    • Teeratakulpisarn, Nipat;
    • Cressey, Tim R.;
    • Anderson, Peter L.;
    • Phanuphak, Nittaya
    Publication type:
    Article
    2
    3

    Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharmacokinetic study in Thailand.

    Published in:
    Journal of the International AIDS Society, 2025, v. 28, n. 4, p. 1, doi. 10.1002/jia2.26445
    By:
    • Hiransuthikul, Akarin;
    • Thammajaruk, Narukjaporn;
    • Kerr, Stephen;
    • Janamnuaysook, Rena;
    • Nonenoy, Siriporn;
    • Hongchookiat, Piranun;
    • Trichavaroj, Rapee;
    • Tawon, Yardpiroon;
    • Boonruang, Jakkrapatara;
    • Teeratakulpisarn, Nipat;
    • Cressey, Tim R.;
    • Anderson, Peter L.;
    • Phanuphak, Nittaya
    Publication type:
    Article
    4

    Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 6, p. 1265, doi. 10.1093/jac/dkp351
    By:
    • Chantarangsu, Soranun;
    • Cressey, Tim R.;
    • Mahasirimongkol, Surakameth;
    • Capparelli, Edmund;
    • Tawon, Yardpiroon;
    • Ngo-Giang-Huong, Nicole;
    • Jourdain, Gonzague;
    • Lallemant, Marc;
    • Chantratita, Wasun
    Publication type:
    Article
    5
    6

    Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 4, p. 633, doi. 10.1093/cid/civ346
    By:
    • Cressey, Tim R.;
    • Avihingsanon, Anchalee;
    • Halue, Guttiga;
    • Leenasirimakul, Prattana;
    • Sukrakanchana, Pra-ornsuda;
    • Tawon, Yardpiroon;
    • Jaisieng, Nirattiya;
    • Jourdain, Gonzague;
    • Podany, Anthony T.;
    • Fletcher, Courtney V.;
    • Klinbuayaem, Virat;
    • Bowonwatanuwong, Chureeratana
    Publication type:
    Article
    7
    8